AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,775,901 | +72.9% | 256,397 | 0.0% | 0.01% | +66.7% |
| Q3 2022 | $11,440,434 | +28.2% | 256,397 | +10.0% | 0.00% | +50.0% |
| Q2 2022 | $8,925,662 | +21.6% | 233,046 | +31.5% | 0.00% | 0.0% |
| Q1 2022 | $7,337,619 | +1.0% | 177,280 | -7.8% | 0.00% | +100.0% |
| Q4 2021 | $7,266,000 | +14.6% | 192,329 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,339,000 | +51.0% | 192,329 | +209.1% | 0.00% | 0.0% |
| Q2 2021 | $4,198,000 | -64.3% | 62,223 | -70.1% | 0.00% | -66.7% |
| Q1 2021 | $11,773,000 | -47.4% | 207,922 | -24.4% | 0.00% | -40.0% |
| Q4 2020 | $22,397,000 | +10.7% | 274,909 | -3.2% | 0.01% | 0.0% |
| Q3 2020 | $20,225,000 | -39.5% | 283,855 | -30.1% | 0.01% | -50.0% |
| Q2 2020 | $33,422,000 | +84.2% | 406,198 | +31.7% | 0.01% | +66.7% |
| Q1 2020 | $18,143,000 | – | 308,392 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |